Chang Gung Biotechnology Corp.

John D Young

Chih-Jung Chang

Chuan-Sheng Lin

Chia-Chen Lu

Chen-Yaw Chiu

David Marcelo Ojcius

Hsin-Chih Lai

Yun-Fei Ko

Jan Martel

Jian-Ching Liau

Tsung-Ru Wu

I-Te Chang

Wei-Chang Wang

Wei-Ting Jian

Mei-Feng Lin

Chia-Jen Yang

The present invention describes a method to reduce blood aspartate transaminase level, liver weight, hepatic lipid accumulation and hepatocyte hypertrophy by administering the probiotic bacteriumto a subject showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease.

[object Object]

The present invention provides a method to reduce insulin resistance and improve glucose tolerance by administering the probiotic bacterium. This probiotic bacterium can therefore be used to treat insulin resistance, metabolic syndrome, and type 2 diabetes.

The present invention describes a method to reduce body weight, fat accumulation and adipocyte size by administering the probiotic bacterium. This probiotic bacterium can therefore be used to treat obesity in animals and humans.

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides can reduce liver weight and liver lipid content in humans and animals. The prepared polysaccharides can therefore be used to prevent and treat fatty liver disease.

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides can reduce hyperglycemia and improve insulin sensitivity in humans and animals, and can therefore be used to prevent and treat type 2 diabetes.

Method to prepare ganoderma lucidum polysaccharides possessing insulin-sensitizing properties and applications thereof

The present invention provides a method to prepare polysaccharides from. The prepared polysaccharides reduce body weight and fat accumulation in laboratory animals, and can therefore be used to prevent and treat obesity.

Growing community of inventors

Taipei, Taiwan

John D Young